Cargando…
Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases
OBJECTIVES: Gamma glutamyl-transpeptidase (GGT) has been shown as a prognostic marker in many cancers. The aim of this study was to explore whether serum GGT could predict tumor recurrence in patients with liver-confined colorectal cancer liver metastases (CRCLM) undergoing R0 resection. METHODS: We...
Autores principales: | Xiao, Binyi, Peng, Jianhong, Tang, Jinghua, Deng, Yuxiang, Zhao, Yujie, Wu, Xiaojun, Ding, Peirong, Lin, Junzhong, Pan, Zhizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444105/ https://www.ncbi.nlm.nih.gov/pubmed/32913447 http://dx.doi.org/10.1177/1758835920947971 |
Ejemplares similares
-
Gamma-glutamyl transferase: risk and prognosis of cancer
por: Fentiman, I S
Publicado: (2012) -
Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center
por: Xiao, Binyi, et al.
Publicado: (2018) -
Serum gamma-glutamyl transferase is a predictor of mortality in patients with acute myocardial infarction
por: Kim, Jae Gyung, et al.
Publicado: (2018) -
Gamma-Glutamyl Transferase Levels in Patients with Acute Ischemic Stroke
por: Gurbuzer, Nurbanu, et al.
Publicado: (2014) -
Association of Serum Gamma-Glutamyl Transferase and Ferritin with the Metabolic Syndrome
por: Wei, Dong, et al.
Publicado: (2015)